🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Flavia Matovu is speaking to Uganda Medical Association Central Branch about the findings of Gilead Sciences PURPOSE 1 study on the twice yearly injectable Lenacapavir for PrEp. You can join the conversation here. Join Zoom Meeting us06web.zoom.us/j/81552508498?… Meeting ID: 815 5250 8498 Passcode: 655562

As we approach World AIDS Day, it's inevitable to feel the wounds of loss of our dear ones. We may have lost so many to HIV, but we have not lost the fight. On page 8 of today's New Vision Johnnie Musenze highlights the progress in finding a preventive drug given once every 6 months.

On #HealthNet ⁦Radio One FM90⁩ we are discussing a new treatment modality for HIV with expert from ⁦MU-JHU Care LTD | MU-JHU Research Collaboration⁩ Dr Flavia Matovu Kiweewa

Lenacapavir is an injectable HIV prevention drug administered twice a year and has been found to be 100% efficient Flavia Matovu MU-JHU Care LTD | MU-JHU Research Collaboration

One of my highlights this month was hosting the Academy of Women Entrepreneurs Conference alongside the amazing Crystal Newman , whose energy was simply infectious! 🎉 We had great discussions on how to support women-led businesses in Uganda to thrive.

Today, Health Journalists Network Uganda (HEJNU OFFICIAL) with support from AVAC, held a science cafe where over 30 health journalists were enriched about HIV prevention options and how people will have choice with the introduction of Lenacapavir in the ANTI-HIV arsenal MU-JHU Care LTD | MU-JHU Research Collaboration Flavia Matovu Uganda AIDS Commission

Health Journalists Network Uganda (HEJNU OFFICIAL) AVAC MU-JHU Care LTD | MU-JHU Research Collaboration Flavia Matovu Uganda AIDS Commission Ministry of Health- Uganda Gilead Sciences ACTS101-Uganda PEPFAR Obulamu USAID in Africa SciDev.Net SS Africa Vital Strategies Thanks for sharing this information about a media science cafe held by Health Journalists Network Uganda (HEJNU OFFICIAL) and supported by AVAC on the PURPOSE 1 trial results shared by Dr. Flavia Kiweewa Matovu, the principal investigator in Uganda. Gilead Sciences

Makerere University and Johnson Hopkins University Scientists (MU-JHU) in a research collaboration are testing a 'wonder' drug known as Lenacapavir injection Prep that has revealed 100% prevention against #HIV . Dr. Flavia Matovu Kiweewa sitting in picture says the drug taken

twice yearly (every 6 months) has been tested amongst 5,000 women prone to acquiring HIV in the districts of Munyama, Kassanda,Mubende, Kalangala and Masaka aged between 16-25 years and it protected them 100%. Dr. Kiweewa adds that their is still no cure for HIV/AIDs. Health Journalists Network Uganda (HEJNU OFFICIAL)

The #AIDSSymposiumUg is underway at the Sheraton Hotel, focusing on Uganda's progress in the fight against HIV/AIDS and strategies to overcome future challenges.

HIV is heterogeneous, as it varies across regions and affects genders differently. This underscores the need for targeted interventions to achieve epidemic control. - Dr. Robert Mutumba , Asst Commissioner AIDS Control Division #AIDSSymposiumUg 📸@geofreymutumba2

We've had oral PrEP for some time now, but stigma has been a barrier for many people, as they fear others might think they're already infected with HIV- Dr. Flavia Matovu ,Makerere University – Johns Hopkins University (MU-JHU) #AIDSSymposiumUg

Lenacapvir is used for the treatment of HIV, but now we are exploring its role in the prevention of HIV. It has been available in the US and Europe for the past two years - Dr. Flavia Kiweewa ,Makerere University(MU-JHU) #AIDSSymposiumUg

Congratulations Dearest Dr Isaac and Dr Ella we love you dearly ❤️❤️❤️❤️

Continuing our celebration of Women's History Month, ASBMR celebrates Flavia Matovu Kiweewa, the 2024 Phoebe Leboy Award Recipient. Hear about Flavia's time as a member of ASBMR. hubs.la/Q039h6l00

Why choice really matters to women. Flavia Matovu

#WestUpdates | KAMPALA Wiiki y’omwaka ogu eya Makerere University kworeka ebibacondorize n’ebi babaasize kuhangahangaho yatandika erizooba aha Freedom Square. Purezidenti Yoweri K Museveni natekateekwa kwigura omu butongore omworeko ogu ogurikuza kumara ebiro 3 📷:Eddie Ssejjoba

Today I visited the Makerere University Research and Innovations Exhibition, and I landed on the stall of the Makerere University- John Hopkins University Research Collaboration (MU-JHU) exhibiting a promising medical breakthrough. I had heard of it rumoured about, here was a chance to

I recently had the utmost honor of talking to the president of Uganda about Gilead Sciences' twice-yearly injection, Lenacapavir that offered 100% protection against HIV acquisition among young women in Uganda and South Africa. #LongactingPrEP #AccessForAll

. Uganda Network of Young People Living with HIV and Hopestone Insight Ug are hosting a X-Space on "HIV & Tech: Can Digital Innovations Power a More Sustainable Response?" Moderated by Ruth Akulu. Let's discuss the future of HIV response together. #CandlelightMemorialDay #EndAIDS2030Ug